KDR and neoplasm: One likely explanation for the proangiogenic reaction is that the VEGFR-2 blockade in glioma cells activates the autocrine/paracrine VEGF/VEGFR-2 signaling pathway by increasing the production of its ligand, VEGF, which could then act on the tumor endothelium.